{"id":"NCT02137785","sponsor":"DUSA Pharmaceuticals, Inc.","briefTitle":"Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities","officialTitle":"A Phase 3 Study of Photodynamic Therapy With Levulan Kerastick Topical Solution + Blue Light Versus Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-05","primaryCompletion":"2015-03","completion":"2015-03","firstPosted":"2014-05-14","resultsPosted":"2015-09-16","lastUpdate":"2015-09-16"},"enrollment":269,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Actinic Keratosis"],"interventions":[{"type":"DRUG","name":"Aminolevulinic Acid (ALA)","otherNames":["Levulan Kerastick"]},{"type":"DRUG","name":"Topical Solution Vehicle","otherNames":[]},{"type":"DEVICE","name":"Blue Light Photodynamic Therapy Illuminator (BLU-U)","otherNames":[]}],"arms":[{"label":"ALA","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if Levulan Photodynamic Therapy (PDT) is safe and effective in the treatment of actinic keratoses on the upper arms and hands","primaryOutcome":{"measure":"Complete Clearance Rate","timeFrame":"Week 12","effectByArm":[{"arm":"ALA-PDT","deltaMin":42,"sd":null},{"arm":"Vehicle","deltaMin":17,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":12},"locations":{"siteCount":13,"countries":["United States"]},"refs":{"pmids":["38125671"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":135},"commonTop":["Nasopharyngitis","Squamous Cell Carcinoma of Skin"]}}